Merit Price To Sales Ratio from 2010 to 2024

MMSI Stock  USD 103.66  0.34  0.33%   
Merit Medical's Price To Sales Ratio is decreasing with very volatile movements from year to year. Price To Sales Ratio is predicted to flatten to 2.66. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Merit Medical's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
3.47930855
Current Value
2.66
Quarterly Volatility
1.74727969
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 106.4 M, Interest Expense of 16.3 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0 or PTB Ratio of 3.6. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Check out the analysis of Merit Medical Correlation against competitors.

Latest Merit Medical's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Merit Medical Systems over the last few years. Price to Sales Ratio is figured by comparing Merit Medical Systems stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Merit Medical sales, a figure that is much harder to manipulate than other Merit Medical Systems multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Merit Medical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.57 X10 Years Trend
Very volatile
   Price To Sales Ratio   
       Timeline  

Merit Price To Sales Ratio Regression Statistics

Arithmetic Mean2.78
Geometric Mean2.44
Coefficient Of Variation62.86
Mean Deviation1.13
Median2.66
Standard Deviation1.75
Sample Variance3.05
Range6.8784
R-Value(0.03)
Mean Square Error3.28
R-Squared0
Significance0.91
Slope(0.01)
Total Sum of Squares42.74

Merit Price To Sales Ratio History

2024 2.66
2023 3.48
2022 3.49
2021 3.25
2020 3.19
2019 1.73
2018 3.3

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Sales Ratio 3.48  2.66 

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.091
Earnings Share
2.04
Revenue Per Share
22.847
Quarterly Revenue Growth
0.078
Return On Assets
0.0456
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.